In the search for a vaccine that protects against a wide range of coronaviruses, the secret could be going sugar-free, one ...

The shingles vaccine is recommended for healthy adults age 50 or older, and also for anyone age 19 years or older who has a weakened immune system (for example, if you have recently been treated for ...

But scientists working on COVID vaccines have one key thing in their ... coli is traditionally used to produce recombinant proteins, but it has quite a low success rate, says Eizo Takashima ...

A recent WHO-led study published in Vaccine provides updated estimates on the global production capacity of influenza ...

Around the world, more than a dozen intranasally delivered COVID-19 vaccines have entered clinical trials, and they run the gamut from adenovirus-vectored genes for viral antigens to recombinant ...

Founded in 1987 in the US, Gale Smith – VP of vaccine development at Novavax – invented the technique of using insect cells for producing recombinant protein vaccines. A further milestone came ...

Recombinant HA protein used to measure serum antibody levels in vaccinated mice 2. Sino Biological unveils comprehensive Influenza research reagents for 2025–2026 vaccine strains Sino Biological, a ...

Neomycin is an antibiotic that interferes with bacterial protein synthesis by binding primarily to the 30S subunit of bacterial ribosomes. Many vaccines contain trace amounts of neomycin to ...

The recombinant zoster vaccine (RZV) Shingrix demonstrated effectiveness in preventing herpes zoster (HZ) and postherpetic neuralgia among adults aged 50 years or older with rheumatoid arthritis (RA).

Strong revenue performance, including approximately $1.9 million milestone and license revenue recognized in 2024Up to $7.5 ...

The Global Recombinant Chemicals Market is valued at approximately USD 2.9 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.8% over the forecast period 2024-2032.